Survival in patients with neuroendocrine tumors of the colon, rectum and small intestine

The 2019 WHO classification of tumours of the digestive system

Irıs D. Nagtegaal, Robert D. Odze, David S. Klimstra et al. · Histopathology · 2019 · 4.1K citations · Full text

Medicine, Oncology, Pathology +17

Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

Arvind Dasari, Chan Shen, Daniel M. Halperin et al. · JAMA Oncology · 2017 · 3.5K citations · Full text

Medicine, Oncology, Surgery +17

Phase 3 Trial of ¹⁷⁷ Lu-Dotatate for Midgut Neuroendocrine Tumors

Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin et al. · New England Journal of Medicine · 2017 · 3.2K citations · Full text

Medicine, Oncology, Pharmacology +17

A 5‐decade analysis of 13,715 carcinoid tumors

Irvin M. Modlin, Kevin D. Lye, Mark Kidd · Cancer · 2003 · 2.7K citations

Medicine, Oncology, Cancer Epidemiology +10

Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study

James C. Yao, Nicola Fazio, Simron Singh et al. · The Lancet · 2015 · 1.3K citations

Medicine, Oncology, Surgery +12